New evidence-based clinical guidelines: expand patient eligibility for weight-loss surgery and support metabolic surgery for people with type 2 diabetes.
Obesity affects around 42 percent of adult Americans in the United States, which raises the risk of having chronic diseases such as diabetes, cancer, and other illnesses.
Obese women who take oestrogen and progestin-containing oral contraceptives have a 24-fold greater risk of venous thromboembolism (VTE) compared to non-obese women who do not use the medicines.
